Screening Innovations and 3D Cell Culture Assay Developments
Showcased at ELRIG
New Tech Aids Drug Discovery
In Scientific Publishing, Sharing Is Caring
The Saga for Open-Access Research Continues
Cell-Free DNA Drives Liquid Biopsy Testing
Researchers Are Diligently Finding Ways to Use Scraps of cfDNA in Clinically Relevant Ways
Raising the Bar of Cell Line Authentication
Researchers May Be Slow to Implement Protocols Unless They Are Pressured
For full access to this article login to GEN Select now.
Cultivating a Drug Discovery Ecosystem
H3 Biomedicine Maintains Multiple Platforms, Generates Diverse Anticancer Drug Candidates
- H3 Biomedicine uses a combination of genomics, synthetic organic chemistry, and tumor biology to develop small molecules for cancer treatment. According to H3’s president and CEO, Markus Warmuth, M.D., “A small molecule approach creates opportunities to go after targets that antibodies can’t tackle.” “There are only so many ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.